Grastek and Ragwitek, sublingual immunotherapy tablets, approved by FDA
Grastek and Ragwitek, sublingual immunotherapy tablets, approved by FDA The FDA approved the ragweed allergy treatment Ragwitek, the third sublingual immunotherapy (SLIT) approval last month. The announcement followed that of Merck’s other SLIT agent, the Timothy grass pollen allergy tablet Grastek, on Tuesday and that of Greer’s multi-grass pollen immunotherapy tablet Oralair earlier in April. While under-the-tongue drops made off-label from…
